90Y-ibritumomab tiuxetan

Pronunciation

A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 90Y-Zevalin, IDEC-Y2B8, and yttrium Y 90-ibritumomab tiuxetan. (NCI Dictionary)

YOU MAY ALSO LIKE

90Y-DOTA-biotin

A compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to…

90th Growth Percentile

An indication that an individual ranks the same or more than 90 percent (top 10 percent) of the reference population for a…

9: 97825196-97857776

Physical location of ANP32B_Gene

9: 91203730-91055664

Physical location of AUH_Gene

9: 87570534-87575862

Physical location of CTSL_Gene

9: 77875746-77564747

Physical location of GNAQ_Gene